Moderna at @ESCMID 2024! 🔬🌍
We're excited to attend the #ESCMIDGlobal Congress in Barcelona, Spain. From key data and research from across our vaccine portfolio, including #COVID19, #influenza, respiratory syncytial virus, and #cytomegalovirus, we’re at the forefront of…
pic.twitter.com/FrqJSYe9BR